Licensing Deal Finalized for Cancer-Targeting Antibodies

A Inpart Case Study

Preview of the The University of Tennessee Case Study

Case study describing how The University of Tennessee used Inpart

View this case study…

The University of Tennessee

Stefan Schweizer

Licensing Associate

Inpart

44 Case Studies